Long-term survival and predictors for mortality among dialysis patients in an endemic area for chronic liver disease: A national cohort study in Taiwan

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Chien, Chih Chiang ^a,b   Wang, Jhi Joung ^a   Sun, Yih Min ^b   Sun, Ding Ping ^a,c   Sheu, Ming Jen ^a,c   Weng, Shih Feng ^a   Chu, Chin Chen ^a   Chen, Hung An ^a   Chio, Chung Ching ^a   Hwang, Jyh Chang ^a   Lu, Yi Hua ^a   Wang, Hsien Yi ^a,c   Kan, Wei Chih ^a,b,d  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^d SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Hemodialysis; Liver cirrhosis; Mortality; Peritoneal dialysis

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CHRONIC LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEMIPLEGIA; HEMODIALYSIS; HUMAN; HYPERTENSION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL HEALTH INSURANCE; NEOPLASM; PARAPLEGIA; PERITONEAL DIALYSIS; RISK FACTOR; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; END STAGE LIVER DISEASE; ENDEMIC DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; SURVIVAL RATE; TAIWAN; TIME FACTORS; YOUNG ADULT;

EID: 84862269178     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-43     Document Type: Article

References (38)

1. United States Renal Data System, Excerpts from the USRDS 2009 annual data report: atlas of end-stage renal disease in the United States, 2011 http://www.usrds.org (accessed August 25, 2011)
2. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance. Yang WC, Hwang SJ, Taiwan Society of Nephrology, Nephrol Dial Transplant 2008 23 3977 3982 10.1093/ndt/gfn406 18628366
3. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Vonesh EF, Snyder JJ, Foley RN, Collons AJ, Kidney Int 2004 66 2389 2401 10.1111/j.1523-1755.2004.66028.x 15569331
4. Mortality risks of peritoneal dialysis and hemodialysis. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, Ma JZ, Am J Kidney Dis 1999 34 1065 1074 10.1016/S0272-6386(99)70012-0 10585316
5. Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. Termorshuizen F, Korevaar JC, Dekker FW, Van Manen JG, Boeschoten EW, Krediet RT, NECOSAD Study Group, J Am Soc Nephrol 2003 14 2851 2860 10.1097/01.ASN.0000091585.45723.9E 14569095 (Pubitemid 37305648)
6. Survival analysis: comparing peritoneal dialysis and hemodialysis in Taiwan. Huang CC, Cheng KF, Wu HD, Perit Dial Int 2008 28 Suppl 3 15 S20 18552246
7. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, Levey AS, Levin NW, Sadler JH, Kliger A, Powe NR, Ann Intern Med 2005 143 174 183 16061915
8. Peritoneal dialysis first: rationale. Chaudhary K, Sangha H, Khanna R, Clin J Am Soc Nephrol 2011 6 447 456 10.2215/CJN.07920910 21115629
9. Hepatitis C infection and chronic renal diseases. Perico N, Cattaneo D, Bikbov B, Remuzzi G, Clin J Am Soc Nephrol 2009 4 207 220 10.2215/CJN.03710708 19129320
10. Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients. Patel PR, Thompson ND, Kallen AJ, Arduino MJ, Am J Kidney Dis 2010 56 371 378 10.1053/j.ajkd.2010.01.025 20570422
11. Review article: Hepatitis B and dialysis. Edey M, Barraclough K, Johnson DW, Nephrology 2010 15 137 145 10.1111/j.1440-1797.2009.01268.x 20470270
12. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. Sun CA, Chen HC, Lu SN, Chen CJ, Lu CF, You SL, J Med Virol 2001 65 30 34 10.1002/jmv.1097 11505440 (Pubitemid 32727003)
13. Viral hepatitis in continuous ambulatory peritoneal dialysis patients in an endemic area for hepatitis B and C infection: the Taiwan experience. Hung KY, Shyu RS, Huang CH, Tsai TJ, Chen WY, Blood Purif 1997 15 195 199 10.1159/000170332 9262846 (Pubitemid 27348344)
14. Comparing survival between peritoneal dialysis and hemodialysis treatment in ESRD patients with chronic hepatitis C infection. Chou CY, Wang IK, Liu JH, Lin HH, Wang SM, Huang CC, Perit Dial Int 2010 30 86 90 20056985
15. Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: a national cohort study in Taiwan. Hwang SJ, Yang WC, Lin MY, Mau LW, Chen HC, Taiwan Society of Nephrology, Nephrol Dial Transplant 2010 25 2616 2624 10.1093/ndt/gfq308 20519231
16. Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. Nakayama E, Akiba T, Marumo F, J Am Soc Nephrol 2000 11 1896 1902 11004221
17. Mortality in hepatitis C-positive patients treated with peritoneal dialysis. Wang SM, Liu JH, Chou CY, Huang CC, Shih CM, Chen W, Perit Dial Int 2008 28 183 187 18332455 (Pubitemid 351552403)
18. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis. Huang CC, Wu MS, Lin DY, Liaw YF, Perit Dial Int 1992 12 31 33 1311963
19. What is the best chronic dialysis modality for ESRD patients with end-stage liver disease? Chaudhary K, Semin Dia 2011 24 414 415 10.1111/j.1525-139X.2011.00907.x
20. Renal replacement therapy in patients with chronic liver disease. Howard CS, Teitelbaum I, Semin Dial 2005 18 212 216 10.1111/j.1525-139X.2005.18315.x 15934968 (Pubitemid 40847279)
21. Renal replacement therapy in end-stage renal disease patients with chronic liver disease and ascites: role of peritoneal dialysis. Chaudhary K, Khanna R, Perit Dial Int 2008 28 113 117 18332442 (Pubitemid 351552390)
22. Peritoneal dialysis in patients with cirrhosis and ascites. Guest S, Adv Perit Dial 2010 26 82 87 21348386
23. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Johnson DW, Dent H, Yao Q, Tranaeus A, Huang CC, Han DS, Jha V, Wang T, Kawaguchi Y, Qian J, Nephrol Dial Transplant 2009 24 1598 1603 10.1093/ndt/gfn684 19096083
24. Bureau of National Health Insurance Available at: www.doh.gov.tw/ statistic/index.htm [In Chinese] (accessed November 25, 2011); http://www.doh.gov.tw/EN2006/index-EN.aspx [In English]
25. United States Renal Data System, Treatment history (chapter V), in Researchers Guide to the USRDS Database 1999 http://www.usrds.org (accessed November 25, 2011)
26. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, N Engl J Med 2004 351 1296 1305 10.1056/NEJMoa041031 15385656 (Pubitemid 39268908)
27. Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Chen HF, Chen P, Li CY, Hepatology 2010 52 155 163 10.1002/hep.23641 20578004
28. Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: evidence from a cohort of a half-million diabetic patients. Chen HF, Ho CA, Li CY, Diabetes Care 2006 29 2409 2414 10.2337/dc06-1343 17065676 (Pubitemid 44912244)
29. Comparing mortality rates on CAPD/CCPD and hemodialysis. The Canadian experience: fact or fiction? Schaubel DE, Morrison HI, Fenton SS, Perit Dial Int 1998 18 478 484 9848625 (Pubitemid 28550348)
30. Initial survival advantage of peritoneal dialysis relative to haemodialysis. Heaf JG, Løkkegaard H, Madsen M, Nephrol Dial Transplant 2002 17 112 117 11773473 (Pubitemid 34093019)
31. Hemodialysis vascular access modifies the association between dialysis modality and survival. Perl J, Wald R, McFarlane P, Bargman JM, Vonesh E, Na Y, Jassal SV, Moist L, J Am Soc Nephrol 2011 22 1113 1121 10.1681/ASN.2010111155 21511830
32. Dementia as a predictor of mortality in dialysis patients. Rakowski DA, Caillard S, Agodoa LY, Abbott KC, Clin J Am Soc Nephrol 2006 1 1000 1005 10.2215/CJN.00470705 17699319
33. Accuracy of patients' reports of comorbid disease and their association with mortality in ESRD. Cavanaugh KL, Merkin SS, Plantinga LC, Fink NE, Sadler JH, Powe NR, Am J Kidney Dis 2008 52 118 127 10.1053/j.ajkd.2008.02.001 18589216 (Pubitemid 351853255)
34. Outcome of peritoneal dialysis in cirrhotic patients with chronic renal failure. De Vecchi AF, Colucci P, Salerno F, Scalamogna A, Ponticelli C, Am J Kidney Dis 2002 40 161 168 10.1053/ajkd.2002.33925 12087574 (Pubitemid 34701224)
35. Reverse epidemiology: a confusing, confounding, and inaccurate term. Levin NW, Handelman GJ, Coresh J, Port FK, Kaysen GA, Semin Dial 2007 20 586 592 10.1111/j.1525-139X.2007.00366.x 17991209
36. Is the inverse relation between blood pressure and mortality normalized in 'low-risk' dialysis patients? Bos WJ, van Manen JG, Noordzij M, Boeschoten EW, Krediet RT, Dekker FW, J Hypertens 2010 28 439 445 10.1097/HJH. 0b013e3283349a3c 19940787
37. Hypertension in the hemodialysis population: any relation to one-year survival? Salem MM, Bower J, Am J Kidney Dis 1996 28 737 740 10.1016/S0272-6386(96)90257-7 9158213 (Pubitemid 26363902)
38. Disease states in which blood pressure is lowered. Loyke HF, South Med J 1989 82 864 867 10.1097/00007611-198907000-00018 2665127 (Pubitemid 19193952)